Genentech’s multiple sclerosis candidate fenebrutinib meets target in late-stage trial
Source link
Savannah Guthrie said, ‘We believe our mother is still there’
Savannah Guthrie said, ‘We believe our mother is still there’ Source link
Genentech’s multiple sclerosis candidate fenebrutinib meets target in late-stage trial
Source link
Savannah Guthrie said, ‘We believe our mother is still there’ Source link
Amentum misses initial and lower estimates; reaffirms the outlook for fiscal year 26 Source link
